- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1094EUR$1,250USD£948GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1094EUR$1,250USD£948GBP
- Clinical Trials
- April 2025
- 60 Pages
Global
From €1750EUR$2,000USD£1,517GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1750EUR$2,000USD£1,517GBP
- Drug Pipelines
- April 2025
- 60 Pages
Global
From €1750EUR$2,000USD£1,517GBP
- Report
- February 2025
- 137 Pages
Global
From €6958EUR$7,950USD£6,030GBP
- Report
- January 2026
- 186 Pages
Global
From €3447EUR$3,939USD£2,988GBP
- Report
- January 2026
- 192 Pages
Global
From €3447EUR$3,939USD£2,988GBP
- Report
- January 2026
- 189 Pages
Global
From €3447EUR$3,939USD£2,988GBP
- Report
- January 2026
- 181 Pages
Global
From €3447EUR$3,939USD£2,988GBP
- Report
- January 2026
- 187 Pages
Global
From €3447EUR$3,939USD£2,988GBP
- Report
- January 2026
- 192 Pages
Global
From €3447EUR$3,939USD£2,988GBP
- Report
- January 2026
- 184 Pages
Global
From €3447EUR$3,939USD£2,988GBP
- Report
- January 2026
- 190 Pages
Global
From €3447EUR$3,939USD£2,988GBP
- Report
- January 2026
- 190 Pages
Global
From €3447EUR$3,939USD£2,988GBP
- Report
- January 2026
- 193 Pages
Global
From €3447EUR$3,939USD£2,988GBP
- Report
- January 2026
- 180 Pages
Global
From €3447EUR$3,939USD£2,988GBP
- Report
- August 2025
- 188 Pages
Global
From €3447EUR$3,939USD£2,988GBP
- Report
- August 2025
- 199 Pages
Global
From €3447EUR$3,939USD£2,988GBP
- Report
- August 2025
- 185 Pages
Global
From €3447EUR$3,939USD£2,988GBP

The Drugs by Therapeutic Area market is a segment of the pharmaceutical industry that focuses on the development and sale of drugs for specific medical conditions. These drugs are designed to treat a wide range of diseases, from cancer to mental health disorders. Companies in this market typically specialize in one or more therapeutic areas, such as oncology, neurology, or cardiology. They develop drugs that target specific medical conditions and then market them to healthcare providers and patients. Companies in this market include Pfizer, Merck, Novartis, GlaxoSmithKline, and Sanofi. Show Less Read more